MOLECULE HOLDINGS (ERV2) — Cash Flow-to-Debt Ratio
MOLECULE HOLDINGS (ERV2) has a Cash Flow-to-Debt Ratio of -0.15x as of October 2022, meaning its operating cash flow of €-1.13 Million could theoretically repay 0% of its total liabilities (€7.61 Million) in one year. See ERV2 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
MOLECULE HOLDINGS Cash Flow-to-Debt Ratio (2021–2022)
Historical debt coverage capacity for MOLECULE HOLDINGS across 2 annual periods. Also explore ERV2 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for MOLECULE HOLDINGS (2021–2022)
Year-by-year debt coverage analysis for MOLECULE HOLDINGS. For market capitalisation and broader financial context, see MOLECULE HOLDINGS (ERV2) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -0.15x | €-1.13 Million | €7.61 Million | ▲ +72.5% |
| 2021 | -0.54x | €-2.87 Million | €5.32 Million | — |